ExploreWatchlistsPricing
  1. US-listed companies
  2. Novo Integrated Sciences, Inc.
  3. Financials
  4. Stockholders' equity

Novo Integrated Sciences, Inc. (NVOS)

Market cap
$69.06K
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Aug 31, 202415-39.99%
Aug 31, 202325+11.26%
Aug 31, 202222-49.15%
Aug 31, 202144+48.08%
Aug 31, 202030+15.78%
Aug 31, 201926+12603.57%
Aug 31, 20180-104.72%
Aug 31, 2017-4-8606.05%
Dec 31, 20160+240.08%
Dec 31, 20150-102.36%
Dec 31, 2014-1-33.99%
Dec 31, 2013-1+18.88%
Dec 31, 2012-1-65.75%
Dec 31, 2011-2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat